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Abstract
Background: Neuroplasticity induced by neonatal inflammation is the consequence of a combination of activity-
dependent changes in neurons. We investigated neuronal sensitivity to a noxious stimulus in a rat model of
neonatal hind-paw peripheral inflammation and assessed changes in pain behaviour at the physiological and
molecular levels after peripheral reinflammation in adulthood.
Results: A decrease in paw withdrawal latency (PWL) after a heat stimulus was documented in rats that received
inflammatory injections in their left hind paws on postnatal day one (P1) and a reinflammation stimulus at
postnatal 6-8 weeks of age, compared with normal rats. An increase in the expression of the prodynorphin
(proDYN) gene was noted after reinflammation in the spinal cord ipsilateral to the afferents of the neonatally
treated hind paw. The involvement of the activation of extracellular signal-regulated kinases (ERK) in peripheral
inflammatory pain hypersensitivity was evidenced evident by the increase in phospho-ERK (pERK) activity after
reinflammation.
Conclusions: Our results indicate that peripheral inflammation in neonates can permanently alter the pain
processing pathway during the subsequent sensory stimulation of the region. Elucidation of the mechanism
underlying the developing pain circuitry will provide new insights into the understanding of the early pain
behaviours and the subsequent adaptation to pain.
Background
Since the clinical demonstration of varied hormonal and
metabolic responses in infants undergoing surgery,
which were attenuated by general anaesthesia, clinicians
have suggested that marked nociceptive activity in pre-
mature or full-term neonates constitutes a physiological,
and perhaps even a psychological, form of stress [1]. An
increased focus on the neurobiology of developing pain
pathways attests the awareness of the importance of
pain in infancy [2]. Previous studies demonstrated
clearly that peripheral inflammation experienced during
the neonatal period has long-standing consequences on
spinal nociceptive neuronal circuits [3,4]. In our recent
studies, we have demonstrated that, during the process
of neonatal neuronal development of the primary affer-
ents following neonatal peripheral inflammation, there is
not only a dynamic change in the pattern and distribu-
tion of calcitonin gene-related peptides (CGRP) contain-
ing terminals in various regions of the dorsal horn, [5]
but also a molecular change in neurotrophic factors,
particularly the nerve growth factor (NGF), and brain-
derived neurotrophic factor (BDNF) [6]. Furthermore, as
behavioural, [7] electrophysiological [8] and immunohis-
tochemistry [9] studies have shown, these changes
induce a subsequent hypersensitization in response to
later sensory stimulation and noxious stimulation.
Thus, it is well established that the central nervous sys-
tem is active during prenatal development, and that detri-
mental and developmental changes resulting from
inflammatory insults lead to central excitability alterations,
which modify later pain-stimulated behaviour patterns
[10,11]. However, little is known about the mechanism
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alterations. In this study, we assessed the variation in the
levels of the proDYN mRNA during the long-term modu-
lation of nociceptive neuronal circuits after neonatal Com-
plete Freund’ Adjuvant (CFA) -induced peripheral
inflammation.
D y n o r p h i ni sac l a s so fe n d o g e n o u so p i o i dp e p t i d e s
that are produced by many different populations of neu-
rons in the hypothalamus, hippocampus and spinal cord
[12]. Although this peptide is classified as an endogen-
ous opioid peptide that binds to the opioid kappa recep-
tors, numerous studies indicate that much of the
pharmacology of this peptide is dependent on its inter-
action with NMDA receptors, rather than with opioid
receptors [13]. Several groups reported that the increase
in spinal dynorphin expression after peripheral noxious
stimulation [14-16] was mediated by the mitogen-
activated protein kinases (MAPK)/extracellular signal-
regulated kinases (ERK) pathway [17] via a positive-
feedback mechanism, which results in neuropathic and
other chronic (e.g., inflammatory) pain states [18,19].
Moreover, the intrathecal administration of dynorphin
induces behavioural signs of hyperalgesia similar to
those observed in central hypersensitization induced by
peripheral inflammation or nerve-injury-induced pain
[20,21]. These experiments support the previous hypoth-
esis that pathological or upregulated levels of spinal
dynorphin play a pro-nociceptive role by maintaining
“central sensitization” i nt h ep o s t - n e r v ei n j u r ys t a t e
[22,23]. In this study, we examined the role of the
MAPK/ERK pathway in the upregulation of dynorphin
in the reinflammation-associated hyperalgesia observed
in adult rats that experienced neonatal inflammatory
insults. Behaviour profiles, gene expression and in situ
hybridization studies were performed to substantiate our
postulation.
Results
Behavioural responses to noxious heat stimuli at different
time points after reinflammation
PWL was evaluated in the neonatal CFA and saline
groups 24 h after reinflammation via CFA injection into
the left hind paw at postnatal age of 6-8 weeks. No dif-
ference in the baseline PWL was found in the neonatal
CFA group (n = 20) compared with the neonatal saline
group (n = 20) (Figure 1). The mean PWL was 15.10 ±
0.41 s for the left hind paw in the neonatal CFA group
and 14.88 ± 0.46 s for the left hind paw in the neonatal
saline group. Twenty-four hours after reinflammation
via CFA injection in the left hind paw, the neonatal
CFA group showed a significant decrease in PWL in the
left hind paws compared with the neonatal saline-
injected left hind paws. The mean PWL was 6.84 ± 0.33
s and 8.59 ± 0.46 s, respectively.
Comparison of proDYN mRNA expression using real-time
RT-PCR
Real-time RT-PCR was performed to compare the rela-
tive proDYN mRNA expression levels in the left side of
the spinal cord (L4-5) in each group 24 hours after CFA
injection into the left hind paw at postnatal age of 6-8
weeks, with standardization to the naive rats (Figure 2).
The Ct relative quantification method was used with the
level of the proDYN mRNA expression presented as the
value of 2
-ΔCt, as described in the method section. A sig-
nificant increase in proDYN mRNA expression was
detected in the neonatal CFA group (n = 10) compared
with its expression levels in the neonatal saline group (n
= 10), the neonatal non-treated group (n = 10) and the
naive group (n = 10). The 2-ΔCt × 100 values were 3.06
± 0.31, 2.25 ± 0.27 and 2.33 ± 0.25 and 0.24 ± 0.07,
respectively. Since the naïve group did not receive any
CFA injection during the neonatal and the adult period,
little or no proDYN mRNA expression was noted. In
contrast, no significant difference in proDYN mRNA
expression was found between the neonatal non-treated
group and the neonatal saline group.
In situ hybridization labelling of proDYN mRNA in the
lumbar dorsal horn
In situ hybridization studies were performed to determine
the levels of expression and the localization of the
Figure 1 Behavioural analysis using thermal tests after
reinflammation. The PWL to a noxious thermal stimulus at baseline
and at 24 h after CFA reinflammation was compared between the
neonatal CFA group and the neonatal saline group. The results
revealed an absence of differences in the baseline PWL to a noxious
thermal stimulus between the neonatal CFA group and the
neonatal saline group. However, 24 h after reinflammation via CFA
injection into the left hind paw, the PWL in the neonatal CFA group
was significantly decreased compared with that observed in the
neonatal saline group (* P < 0.05).
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CFA group. Twenty-four hours after reinflammation with
CFA in both hind paws of the neonatal CFA group at
postnatal age of 6-8 weeks, there was a significant increase
in the number of cells that expressed proDYN mRNA in
the left dorsal horn, ipsilateral to the afferents of the neo-
natally CFA-treated left hind paw, compared to the right
dorsal horn. The proDYN gene is primarily expressed in
the superficial laminae (laminae I and II) and the deeper
laminae (laminae III and IV) of the dorsal horn (Figure
3A). A higher magnification of the superficial laminae
revealed that the proDYN mRNA-positive cells were
mainly distributed in laminae I and II, with a higher inten-
sity of labelling in the left dorsal horn (Figure 3B) com-
pared with the right dorsal horn (Figure 3C). The
comparison of the number of proDYN-positive cells
between the left and right superficial dorsal horns revealed
that the mean spinal cord laminae I- and II-positive gang-
lia on the left side was 100.33 ± 5.17, vs. 75.00 ± 7.77 on
the right side. The difference was significant (P < 0.05).
The mean L4/L5 laminae III to V positive cells on the left
side was 28.33 ± 5.84, vs. 22.00 ± 4.62 on the right side.
The difference was not significant (Figure 4).
pERK activation after CFA-induced peripheral
inflammation
To investigate whether the cellular MAPK/ERK signal
pathway was involved in spinal pain signal transduction,
the levels of pERK and total ERK proteins extracted
from the spinal cord of animals in the neonatal CFA
and saline groups 10 min after peripheral reinflamma-
tion were examined using Western blotting. Staining of
the different isomers of the pERK protein revealed an
increase in density in the neonatal CFA group (n = 6)
compared with that observed in the neonatal saline (n =
6) and the naive groups (n = 6) (Figure 5A). The inten-
sity of the total ERK proteins was the same in all
groups. The Western blots supports Figure 5B, which
shows that, 10 min after reinflammation with CFA at
postnatal age of 6-8 weeks, the ratio of pERK to total
ERK (pERK/ERK) in the neonatal CFA group was signif-
icantly higher compared with the ratio observed in the
neonatal saline group and in the naïve group (P < 0.05).
This suggests an increased pERK protein concentration
in the neonatal CFA group.
Discussion
Advances in medical technology led to a substantial
improvement in the chances of survival of medically com-
promised newborns via the development of therapies,
which often inflict tissue injury and pain. The existence of
background pain in these children not only influences
their acute pain experience but often also leads to a signifi-
cantly lower pain threshold compared with their healthy
Figure 2 Determination of proDYN mRNA expression levels in
the spinal cord after reinflammation using real-time RT-PCR.A
significant increase in proDYN mRNA expression was found in the
neonatal CFA group compared with the neonatal non-treated and
neonatal saline groups 24 h after reinflammation with CFA (* P <
0.05). No significant differences in proDYN expression levels was
noted between the neonatal non-treated group and the neonatal
saline group. Little or no proDYN expression was noted in the naïve
group, which did not receive any CFA injection during the neonatal
and the adult time.
Figure 3 In situ hybridization study showing an upregulation
of the proDYN mRNA in the dorsal horns after reinflammation.
A low-magnification image shows neurons expressing spinal
proDYN mRNA in the superficial and deeper laminae of the dorsal
horn 24 h after reinflammation in the CFA group (A). A high-
magnification image of Figure 3A shows a comparable increase in
proDYN mRNA-positive neurons in laminae I-II of the dorsal horn
ipsilateral (B) side that experienced neonatal peripheral
inflammation compared with the contralateral side, which did not
receive neonatal peripheral CFA insults (C). Scale bars: a, 200 μm; b
and c, 100 μm
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tors [24]. Studies showed that early injury in the first post-
natal weeks leads to the development of neural circuits
that permanently alter pain perception [25]. Furthermore,
it was also demonstrated that short-lasting inflammatory
insults during the neonatal period generate hypoalgesia in
adults [4,7,26]. This is compatible with the present beha-
viour studies, which revealed a generalized reduction in
baseline sensitivity in response to a noxious heat stimulus.
In contrast, neonatal injury can also have the opposite
effect. Long-term hyperalgesia, although masked at the
segmental level, [27-29] was uncovered after a much
greater stimulus (such as reinflammation) was applied.
This reinflammation-associated hyperalgesia reflected an
inflammatory challenge, which strengthens the nociceptive
signal transduction pathway [8,9] and leads to a reduction
in hypoalgesia [30]. Although the signalling system that
underlies the adult hyperalgesia observed after neonatal
peripheral inflammation is poorly understood, it is now
known that neural plasticity is fully functional at birth and
the somatosensory nervous system, though immature, is
fully capable of transmitting sensory information [25,31].
In the present study, a decrease in PWL was found 24 h
after CFA-induced reinflammation in the neonatal CFA
group compared with the neonatal saline group. This
observation was consistent with our previous results [3,30]
and with results from other studies [4,26]. These studies
all point to the conclusion that increased pain sensitivity
in adults may develop in rats that experienced peripheral
inflammatory insults during the neonatal period.
Numerous factors have been implicated in hyperalge-
sia as outcomes of early peripheral noxious experience,
including substance P, the NMDA receptor, pERK,
dynorphin, and c-fos [17,32-36]. However, studies that
looked into the mechanism that underlies the hyperalge-
sia induced by reinflammation in rats that received neo-
natal noxious stimuli are scarce. In the present study,
the assessment of the expression of the proDYN gene
using quantitative real-time RT-PCR revealed the upre-
gulation of this gene after reinflammation in the spinal
cord in the neonatal CFA group compared with the
neonatal saline group, 24 hours after reinflammation via
CFA injection. The in situ hybridization analysis showed
that this increased expression of proDYN after reinflam-
mation was primarily localized to the superficial laminae
I and II of the dorsal horn ipsilateral to the site of the
neonatal insult, in the area where nociceptive afferent
projections, such as A-delta and C fibres, terminate. No
significant difference was noted in the expression of
proDYN in the neck of the dorsal horn (laminae V and
VI) between the two sides of the spinal cord of the neo-
natal CFA group after the bilateral induction of
reinflammation.
Figure 4 Quantification of proDYN mRNA-positive neurons
using in situ hybridization in laminae I-II and laminae III-V of
the dorsal horn 24 h after reinflammation with CFA injection
into bilateral hind paws at postnatal time 6-8 weeks in the
neonatal CFA group. A significant increase in the number of
proDYN mRNA-positive neurons was found in laminae I-II of the left
side that received a neonatal peripheral CFA insults compared to
the right dorsal horn, which did not receive neonatal CFA insults (*
P < 0.05). There was also an increase in the number of proDYN
mRNA-positive neurons in laminae III-V of the neonatal CFA-treated
side compared with the contralateral side; however, this difference
was not significant.
Figure 5 Western blot analysis of pERK activation in spinal
cords subjected to CFA-induced peripheral reinflammation.
Western blots of spinal cord tissues from animals in the neonatal
CFA group, neonatal saline group and the naive group revealed
varied immunoreactivity against different isomers of pERK 10 min
after reinflammation (A). The intensity of the total ERK was the same
in the three groups. A significant increase in pERK activity was
found in the spinal cord tissues of animals in the neonatal CFA
group compared with the neonatal saline group and the naive
group (* P < 0.05) (B).
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nociceptive properties, [23] plays an important role in
promoting and maintaining neuropathic pain. Although
dynorphin at submicromolar concentrations may acti-
vate opioid receptors to reduce calcium influx, thus
leading to hypoalgesia, [21]a th i g h e rc o n c e n t r a t i o n s
(10-100 μM) dynorphin is pro-nociceptive in some
pathological pain states via interaction with the NMDA
receptor, which leads to allodynia [17,20]. In our real-
time RT-PCR experiments, we observed a significant
increase in proDYN expression after reinflammation in
adult rats that experienced inflammatory insults during
the neonatal period (neonatal CFA group) compared
with rats that received a saline injection during the neo-
natal period (neonatal saline group). Concomitantly, the
neonatal CFA group also exhibited behaviours of hyper-
algesia, which manifested via a significant decrease in
PWL compared with the neonatal saline group. This
peripheral-inflammation-associated hyperalgesia was
previously discussed in a study by Dubner and Ruda
[15]. These authors found that an increase in neuronal
activity in response to tissue injury may lead to changes
in gene expression and prolonged changes in the ner-
vous system, which may contribute to hyperalgesia. This
increase was most evident 24 h after the inflammation
insult. This activity-dependent plasticity may involve
nociceptive processing neuropeptides, such as dynor-
phin, substance P and the calcitonin gene-related pep-
tide. In fact, previous papers have shown that spinal
dynorphin may promote pain, in part, by enhancing the
evoked release of excitatory transmitters such as CGRP
from primary afferents in the dorsal root ganglia [37].
Neurons exhibiting proDYN upregulation in the superfi-
cial and deep laminae of dorsal horn were projection
neurons that convey nociceptive information. Our pre-
vious studies revealed that a neonatal inflammatory sti-
mulus resulted in an increase in the expression of the
neurotrophin receptor gene in dorsal root ganglia during
the early postnatal period [6]. Release of growth factors,
such as NGF, has been implicated with an increase in
the terminal density of nociceptors both in the spinal
dorsal horn [5] and in the injured region, which alters
the development of the nociceptors [38,39]. Similarly,
the upregulation of proDYN secondary to a peripheral
inflammatory insult during the neonatal period can also
be associated with the increase in the density of neuro-
nal terminals, which may occur during the period of the
neonatal insults.
In this study, we also investigated the role of the
MAPK/ERK pathway in the modulation of nociceptive
neuronal circuits in rats that received CFA-induced per-
ipheral insults during the neonatal period. We detected
the upregulation of pERK in the spinal cord of rats in
the neonatal CFA group compared with the neonatal
saline group, after reinflammation. ERK plays a pivotal
role in functional nociceptive plasticity, which in turn
contributes to altered sensibility [40]. Previous studies
pointed out that ERK activation is likely to regulate the
expression of proDYN via transactivators, such as
pCREB and c-fos [41,42]. The link between the ERK
activation and proDYN expression was investigated in a
study by Woolf et al. in which they used a MEK Inhibi-
tor U0126, which is a chemically synthesized organic
compound that inhibits the kinase activity of MAP
kinase, to block ERK activation and subsequently found
ad e c r e a s ei nt h eC F A - i n d u c e dp r o D Y Nm R N Ae x p r e s -
sion [17]. Our results were compatible with the findings
of other studies, in that an increased pERK level was
associated with an increase in the expression of the pro-
DYN mRNA, which may contribute to the development
of reinflammation-induced pain hypersensitivity
(decreased PWL) after neonatal peripheral inflammation.
Conclusion
This study explored the molecular mechanisms that
underlie adult pain hypersensitivity after neonatal per-
ipheral inflammatory insults. The spinal upregulation of
endogenous proDYN observed in our model may parti-
cipate in the development of reinflammation-associated
pain hypersensitivity in adults after neonatal peripheral
inflammatory insults. The study of the development of
the nociceptive showed that pain in newborns involves
functional signalling pathways that are not found in the
mature nervous system of adults [31]. The results of our
studies suggest that peripheral inflammation in neonates
could result in lasting alterations in nociceptive path-
ways. We postulate that the activation of dynorphin via
the MAPK/ERK pathway contributes to the reinflamma-
tion-associated hyperalgesia observed in adult rats that
experienced neonatal peripheral inflammatory insults.
Methods
Animals and inducement of inflammation
Timed-pregnant Sprague Dawley rats were monitored to
determine the time of birth of litters. One hundred neo-
natal rats were separated into four groups. The first
group included rats that received Complete Freund’
Adjuvant (CFA) injections into their left hind paws both
on postnatal day 1 and again at postnatal age of 6-8
weeks (neonatal CFA group; n = 34). The second group
received a saline injection into the left hind paws on
postnatal day 1 and CFA injection at postnatal age of 6-
8 weeks (neonatal saline group; n = 34). The third
group did not receive any kind of injection into their
left hind paws on postnatal day 1, but received CFA
injection at postnatal age of 6-8 weeks (neonatal no-
treatment group; n = 22). The last group of rats did not
receive any injection on postnatal day 1 or at postnatal
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tal inflammation and adult reinflammation were per-
formed as described in Ruda et al [30]. For the neonatal
CFA group, each male rat pup received a single, unilat-
eral subcutaneous injection of CFA into the left hind
paw (CFA:saline, 2:1; 25 μl) (Sigma Chemical Co., St.
Louis, MO) on postnatal day 1. The same volume of sal-
ine was injected into the left hind paw of animals in the
neonatal saline group, on the same day. The animals
were allowed to mature to adulthood without further
manipulation. To induce reinflammation in adult rats in
the neonatal CFA group, the neonatal saline group, and
the neonatal no-treatment group at the postnatal age of
6-8 weeks (P42-56), 200 μl of CFA (CFA:saline,1:1) were
injected unilaterally into the plantar surface of the hind
paws, to perform behaviour assessment of these animals,
as well as the gene expression quantification and
Western blotting experiments. For the in situ hybridiza-
tion experiments, the CFA-induced reinflammation was
applied bilaterally in the neonatal CFA group at postnatal
age of 6-8 weeks, to compare the number of proDYN-
positive nuclei between the two sides of the spinal
column. All procedures used in this study were approved
by the Animal Research Facility of Cathay Medical
Research Institute, Cathay General Hospital, and fol-
lowed the guidelines for the treatment of animals of the
International Association for the Study of Pain [43].
Behavioural assessments
The PWL to a noxious radiant heat stimulus was deter-
mined as described in Hargreaves et al [44]. At 8-10
weeks of age, the baseline PWL of the left hind paw to
a radiant heat source was determined in rats in the neo-
natal CFA group and in the neonatal saline group. Heat
hyperalgesia was tested 24 hours after the injection of
CFA into the left hind paw and was measured four
times at intervals of 5 min. PWL was calculated by com-
bining and averaging the mean latencies of three stimu-
lus presentations to each hind paw, excluding the first
familiarization trial.
Tissue collection
Rats in the neonatal CFA group and neonatal saline
group were euthanized after CFA injection. For the
quantification of mRNA expression levels, animals from
each time point of the behavioural experiments were
euthanized via intraperitoneal injection of an overdose
of sodium pentobarbital (50 mg/kg). The L4 and L5 dor-
sal root ganglia (DRG) were exposed and their roots
were traced up to the entry points on the spinal cord
using a surgical microscope. The lumbar spinal cord
containing the L4-5 segments was removed and the tis-
s u ew a ss e c t i o n e da l o n gt h em i d l i n ei n t ot h el e f t( i . e . ,
projecting side of neonatal CFA-treated animals) and
right sides. Tissues were frozen at -80°C until the isola-
tion of RNA. For the in situ hybridization experiments,
rats were deeply anesthetized with pentobarbital and
perfused transcardially with saline, which was followed
by incubation in 4% paraformaldehyde in 0.1 M phos-
phate buffer (pH 7.4). The L4-5 spinal cord segments
were removed and postfixed for 2-4 h before transfer-
ring to a 30% sucrose/PBS solution and incubation over-
night at 4°C.
Isolation of RNA and real-time RT-PCR quantification
Total RNA was isolated using the 3-Zol reagent
(MDBio, Inc., Taipei, Taiwan) method and the RNA
samples were treated with DNase I (Ambion, TX, USA)
to remove traces of genomic DNA. To ensure optimal
DNase I activity, the buffer conditions in the RNA solu-
tion were adjusted accordingly. RNA absorbance was
measured at 260 nm using a spectrophotometer to
obtain a yield in microgram per microlitre (μg/μl). Taq-
Man Gene expression assays (Applied Biosystems, NJ,
USA) were used in a two-step RT-PCR process. First-
strand cDNA was synthesized from 2 μgo ft o t a lR N A
using SuperScriptTM (Invitrogen, CA, USA) in 10 μlo f
total reaction solution. Real-time PCR reactions were
then performed using an ABI PRISM 7300 Sequence
Detection System (Applied Biosystems, NJ, USA). The
sequence of the published proDYN cDNA was obtained
from GenBank, of the National Center for Biotechnol-
ogy Information (GenBank: NM019374). The actual
sequences of the upstream and downstream PCR pri-
mers and of the probe oligonucleotide for proDYN were
as follows: upstream primer, 5’-CGGCCATCCTAT-
CACCTGA-3’; downstream primer, 5’-CCTTC
CTGCGTGCTGCTT-3’; probe oligonucleotide, 5’-(6-
FAM)CAGCCAGAAGCCTGCCAGCGA-3’,w h e r e6 -
FAM represents 6-carboxyfluorescein. The b-actin
housekeeping gene was similarly amplified using Taq-
Man Rodent Control Reagents. For gene quantification,
2 μl of RT reaction were combined with 1 × TaqMan
Universal Master Mix (Applied Biosystems, NJ, USA).
The reactions were then thermally cycled for 10 min at
95°C, followed by 40 cycles of denaturation (15 s at 95°C)
and annealing/extension for 60 s at 60°C. Data were then
collected via instrument spectral compensations using
the ABI PRISM Sequence Detection Software, version
1.6.3 (Applied Biosystems, NJ, USA), and analysed using
the threshold cycle (Ct) relative quantification method
(the 2
-ΔCt method). The Ct indicates the fractional cycle
number at which the amount of amplified target reaches
a fixed threshold. This method is used to determine the
effect of the experimental treatment on the expression of
a candidate gene against the internal control gene; in our
study, the proDYN gene and the b-actin gene, respec-
tively. For each of the mRNA sample, the value of ΔCt
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v a l u ef o rt h ep r o D Y Ng e n em i n u st h ea v e r a g eC tv a l u e
for the internal control gene b-actin in the same RNA
preparation. The value of the normalized proDYN gene
expression against the internal control gene b-actin gene
expression was then indicated by the value of 2
-ΔCt × 100
[45].
Protein extraction and Western blot analysis
Frozen tissues were groundi n t oap o w d e ra n dr e s u s -
pended in RIPA buffer (50 mM Tris-HCl, pH7.5, 150
mM NaCl, 10 mM EDTA, 1% NP-40 and 0.1% SDS)
with the Protease Inhibitor Cocktail (Roche, Basel,
Switzerland) and the Phosphatase Inhibitor Cocktails I
and II (Sigma St. Louis, MO, USA). The suspended
solution was sonicated on ice for 5 min. The debris was
removed by centrifugation and the supernatant was used
in subsequent experiments. Protein concentration was
determined using the BCA protein assay kit (Pierce,
Rockford, IL, USA) and bovine serum albumin was used
as the standard. The samples were then loaded onto a
10% SDS-PAGE gel and subsequently transferred onto a
PVDF membrane. Prior to sample application, each
PVDF membrane (Perkin-Elmer, Boston, MA, USA) was
sequentially preincubated with methanol and a buffer
containing 48 mM Tris-HCl, 40 mM glycine, 0.0375%
SDS and 20% methanol (pH 9.2). After the electrotrans-
fer of proteins, the membranes were first incubated in
TBST buffer (10 mM Tris-HCl pH 7.5, 150 mM NaCl,
0.05% Tween-20) containing 5% BSA (Sigma St. Louis,
MO, USA) for 1 h at room temperature and were then
probed with anti-ERK antibodies (Cell Signaling, Dan-
vers, MA, USA) at a concentration of 1:1000 in TBST
with 5% BSA for 1 h, or with anti-pERK antibodies (also
termed anti-pMAPK) (Cell Signaling, Danvers, MA,
USA) at a concentration of 1:200 in TBST with 5% BSA
overnight. The membranes were washed with TBST
four times and were then incubated with a horseradish
peroxidase-conjugated goat anti-rabbit secondary anti-
body (Millipore, Billerica, MA, USA) at a concentration
of 1:1000 in TBS for 1 h. The immunopositive proteins
were detected using the ECL reagent (Pierce) and the
chemiluminescence was visualized using Biomax MR
film (Kodak, Rochester, NY, USA). The intensity of each
band was quantified using the LabWorks software (UVP
Bioimaging Systems, Upland, CA, USA).
PCR amplification of rat proDYN cDNA fragments
Sets of specific primers were designed to amplify unique
DNA fragments corresponding to regions of the rat pro-
DYN gene using RT-PCR. The primer sequences for
proDYN were as follows: 5’-GAGGACTTGAGAAAA-
CAGGCC-3’ and 5’-GGTATTGGGGTTCTCCTGGGA-
3’. RT-PCR was implemented as follows. Total RNA
(100 ng) was denatured at 70°C for 5 min and reverse
transcribed into first-strand cDNA by priming with an
oligo(dT) primer. PCR was performed using the Advan-
tage PCR System (Clontech, CA, USA) with the follow-
ing program cycles: one cycle (2 min at 95°C); 35 cycles
(15 s at 94°C, 15 s at 50°C and 1 min at 68°C); and one
cycle (10 min at 72°C). PCR products were resolved by
electrophoresis on 1% agarose gels and the proDYN
cDNA fragment (450 bp) was extracted using the QIA-
quick® kit (QIAGEN, MD, USA).
In situ hybridization
To evaluate the expression of the proDYN gene, in situ
hybridization was performed in the spinal cord of rats
that received neonatal CFA treatment. Animals were
euthanized 24 h after reinflammation with a bilateral
injection of CFA at postnatal week 6-8. The L4-5 spinal
cord segments were removed and sectioned on a cryo-
stat at a thickness of 20 μm. The antisense RNA probe
and the corresponding sense control probe were labelled
via in vitro transcription using linearized DNA templates
for proDYN and digoxigenin (DIG) labelling mixture
(Roche, Mannheim, Germany) for 2 h at 37°C. In situ
hybridization was processed as described previously
[17]. Tissue sections were air dried for 2 h, fixed in 4%
paraformaldehyde for 15 min and acetylated in acetic
anhydride (0.25%) for 10 min. Sections were pre-hybri-
dized for 2 h at room temperature and were then incu-
bated in hybridization buffer overnight at 60°C. Sections
were then washed in decreasing concentrations of SSC
( 2× ,1× ,a n d0 . 2× )f o r2h ,b l o c k e dw i t h2 %g o a t
serum for 1 h and incubated overnight at 4°C with an
alkaline-phosphatase-conjugated anti-DIG antibody
(1:500; Roche, Penzberg, Germany). Finally, sections
were visualized after being incubated in 75 μg/ml nitro-
blue-tetrazoliumchloride, 50 μg/ml 5-bromo-4-chloro-3-
indolyl-phosphate, and 0.24 mg/ml levamisole for 6-8 h.
Quantification and statistical analyses
Statistical evaluation was performed using GraphPad
Prism 5.0 for Windows. All data are presented as the
mean ± standard error (S.E.M.). The time course of
PWL to thermal stimulation and the ΔCt of real-time
RT-PCR were analysed in the radiant heat tests and
gene expression experiments, respectively. Differences in
the density of specific bands between groups were com-
pared in the Western blot experiments. Three neonatal
CFA rats were euthanized for the in situ hybridization
experiment. Six nonadjacent sections from the L4-5
lumbar spinal cord of each of the three neonatal CFA
rats were randomly selected and the number of mRNA-
positive neuronal profiles in the superficial laminae and
deep laminae of the dorsal horn of each section were
counted blindly by an observer. Statistical comparisons
of the values observed in response to reinflammation via
Lin et al. BMC Neuroscience 2010, 11:139
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Page 7 of 9CFA injection at different time points between the neo-
natal CFA group and the neonatal saline group were
performed via analysis of variance (ANOVA) using the
treatments as factors, followed by Tukey’s post hoc
comparisons among the treatment groups. Differences
were considered significant at P < 0.05.
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